Europe Viral-Vectored Vaccines Market Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 128
Inquire Before Buying

Notes:

Sales, means the sales volume of Viral-Vectored Vaccines

Revenue, means the sales value of Viral-Vectored Vaccines

This report studies sales (consumption) of Viral-Vectored Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Viral-Vectored Vaccines in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Viral-Vectored Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Viral-Vectored Vaccines Market Report 2016

Table of Contents
Europe Viral-Vectored Vaccines Market Report 2016
1 Viral-Vectored Vaccines Overview
1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Viral-Vectored Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Viral-Vectored Vaccines Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Viral-Vectored Vaccines (2011-2021)
1.5.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
1.5.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
2 Europe Viral-Vectored Vaccines by Manufacturers, Type and Application
2.1 Europe Viral-Vectored Vaccines Market Competition by Manufacturers
2.1.1 Europe Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Viral-Vectored Vaccines (Volume and Value) by Type
2.2.1 Europe Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
2.2.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Viral-Vectored Vaccines (Volume and Value) by Countries
2.3.1 Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Viral-Vectored Vaccines (Volume) by Application
3 Germany Viral-Vectored Vaccines (Volume, Value and Sales Price)
3.1 Germany Viral-Vectored Vaccines Sales and Value (2011-2016)
3.1.1 Germany Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
3.1.2 Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
3.1.3 Germany Viral-Vectored Vaccines Sales Price Trend (2011-2016)
3.2 Germany Viral-Vectored Vaccines Sales and Market Share by Manufacturers
3.3 Germany Viral-Vectored Vaccines Sales and Market Share by Type
3.4 Germany Viral-Vectored Vaccines Sales and Market Share by Application
4 France Viral-Vectored Vaccines (Volume, Value and Sales Price)
4.1 France Viral-Vectored Vaccines Sales and Value (2011-2016)
4.1.1 France Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
4.1.2 France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
4.1.4 France Viral-Vectored Vaccines Sales Price Trend (2011-2016)
4.2 France Viral-Vectored Vaccines Sales and Market Share by Manufacturers
4.3 France Viral-Vectored Vaccines Sales and Market Share by Type
4.4 France Viral-Vectored Vaccines Sales and Market Share by Application
5 UK Viral-Vectored Vaccines (Volume, Value and Sales Price)
5.1 UK Viral-Vectored Vaccines Sales and Value (2011-2016)
5.1.1 UK Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
5.1.2 UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
5.1.5 UK Viral-Vectored Vaccines Sales Price Trend (2011-2016)
5.2 UK Viral-Vectored Vaccines Sales and Market Share by Manufacturers
5.3 UK Viral-Vectored Vaccines Sales and Market Share by Type
5.4 UK Viral-Vectored Vaccines Sales and Market Share by Application
6 Russia Viral-Vectored Vaccines (Volume, Value and Sales Price)
6.1 Russia Viral-Vectored Vaccines Sales and Value (2011-2016)
6.1.1 Russia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
6.1.2 Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
6.1.6 Russia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
6.2 Russia Viral-Vectored Vaccines Sales and Market Share by Manufacturers
6.3 Russia Viral-Vectored Vaccines Sales and Market Share by Type
6.4 Russia Viral-Vectored Vaccines Sales and Market Share by Application
7 Italy Viral-Vectored Vaccines (Volume, Value and Sales Price)
7.1 Italy Viral-Vectored Vaccines Sales and Value (2011-2016)
7.1.1 Italy Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
7.1.2 Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
7.1.7 Italy Viral-Vectored Vaccines Sales Price Trend (2011-2016)
7.2 Italy Viral-Vectored Vaccines Sales and Market Share by Manufacturers
7.3 Italy Viral-Vectored Vaccines Sales and Market Share by Type
7.4 Italy Viral-Vectored Vaccines Sales and Market Share by Application
8 Spain Viral-Vectored Vaccines (Volume, Value and Sales Price)
8.1 Spain Viral-Vectored Vaccines Sales and Value (2011-2016)
8.1.1 Spain Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
8.1.2 Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
8.1.8 Spain Viral-Vectored Vaccines Sales Price Trend (2011-2016)
8.2 Spain Viral-Vectored Vaccines Sales and Market Share by Manufacturers
8.3 Spain Viral-Vectored Vaccines Sales and Market Share by Type
8.4 Spain Viral-Vectored Vaccines Sales and Market Share by Application
9 Benelux Viral-Vectored Vaccines (Volume, Value and Sales Price)
9.1 Benelux Viral-Vectored Vaccines Sales and Value (2011-2016)
9.1.1 Benelux Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
9.1.2 Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Viral-Vectored Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Viral-Vectored Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Viral-Vectored Vaccines Sales and Market Share by Type
9.4 Benelux Viral-Vectored Vaccines Sales and Market Share by Application
10 Europe Viral-Vectored Vaccines Manufacturers Analysis
10.1 Bayer HealthCare AG (Germany)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Biogenesis-Bago (Argentina)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim GmbH (Germany)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Ceva Sante Animale (France)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Heska Corporation (US)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Indian Immunologicals Ltd (India)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Lohmann Animal Health (US)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Merck Animal Health (US)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Merial Ltd. (US)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Protein Sciences Corporation (US)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Viral-Vectored Vaccines Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Virbac SA (France)
10.12 Zoetis Inc. (US)
11 Viral-Vectored Vaccines Manufacturing Cost Analysis
11.1 Viral-Vectored Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Viral-Vectored Vaccines
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Viral-Vectored Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Viral-Vectored Vaccines Market Forecast (2016-2021)
14.1 Germany Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.2 France Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.3 UK Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.4 Russia Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.5 Italy Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.6 Spain Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.7 Benelux Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.8 Europe Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Viral-Vectored Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table Europe Viral-Vectored Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table Europe Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Europe Viral-Vectored Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Europe Viral-Vectored Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Application (2011-2016)
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Germany Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure France Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure France Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table France Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table UK Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Russia Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Italy Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Spain Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Benelux Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Table Viral-Vectored Vaccines Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Non-Gelatin Empty Capsules Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the EMEA Non-Gelatin Empty Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Non-Gelatin Empty Capsules for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy a......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Asia-Pacific Succinylated Keyhole Limpet Hemocyanin Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the Asia-Pacific Succinylated Keyhole Limpet Hemocyanin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Succinylated Keyhole Limpet Hemocyanin for these regions, from 2012 to 2022 (forecast), including - China......
  • Asia-Pacific Sulbactam Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Sulbactam market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Sulbactam for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan ......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • EMEA (Europe, Middle East and Africa) Peritoneal Dialysis Solution Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the EMEA Peritoneal Dialysis Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K L), revenue (Million USD), market share and growth rate of Peritoneal Dialysis Solution for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Ital......
  • Asia-Pacific Tramadol Hcl Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Tramadol Hcl market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Tramadol Hcl for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs